Where now the diuretics in antihypertensive treatment?

Area of Science:

• Cardiology
• Pharmacology

Background:

• The primary goal of hypertension treatment is to decrease cardiovascular mortality and morbidity.
• Diuretics have demonstrated efficacy in achieving this goal in long-term trials.
• Recent guidelines suggest newer agents like calcium antagonists and ACE inhibitors are equally valuable.

Purpose of the Study:

• To address the lack of definitive long-term trials comparing older and newer antihypertensive agents.
• To resolve the ongoing debate regarding the optimal first-line therapy for hypertension.

Main Methods:

• Review of existing long-term clinical trials on antihypertensive therapies.
• Analysis of comparative effectiveness of diuretics, beta-blockers, calcium antagonists, ACE inhibitors, and alpha-adrenoceptor blockers.

Main Results:

• Diuretics and beta-blockers have not shown differential effects on overall cardiovascular outcomes compared to each other.
• Recommendations for newer agents as equally valuable are speculative and lack endpoint-driven trial support.
• There is a need for direct, long-term comparative trials using cardiovascular mortality and morbidity as endpoints.

Conclusions:

• Current evidence does not definitively support newer antihypertensive drugs over older ones as first-line therapy.
• Further long-term trials are essential to resolve the debate on optimal first-line hypertension treatment.
• The choice of first-line antihypertensive medication remains unresolved pending more robust comparative data.